C hemical signaling between neurons in the brain can be divided into two major categories: fast synaptic transmission and neuromodulation. Fast synaptic transmission, mediated by amino acids such as glutamate and GABA, occurs on millisecond time scales and results in the influx of ions through ligand-gated ion channels on postsynaptic neurons ( Figure 1A ). Electrophysiological and optical imaging tools, including genetically encoded voltage indicators, have enabled neuroscientists to link cause (neurotransmitter release) and effect (membrane polarization) of synaptic transmission in time and space. Unlike classical neurotransmitters, neuromodulators do not produce immediate electrical effects that excite or inhibit target neurons. Instead, neuromodulators tune the intrinsic or synaptic properties of neurons, most commonly through interaction with G-protein-coupled receptors (GPCRs) ( Figure 1B ). Neuromodulators can escape the synaptic cleft and diffuse broadly, allowing them to influence the activity of many neurons in a state-dependent manner. Therefore, the spatial component of neuromodulator flux is fundamentally important. However, the temporal and/or spatial limitations of techniques classically used to study neuromodulation, such as microdialysis and fast-scan cyclic voltammetry (FSCV), make it difficult to interpret how neuromodulator release affects the plasticity or function of target neuronal populations on a moment-to-moment basis. Therefore, tools that can detect neuromodulators with high spatiotemporal resolution are critical for understanding their impact on neural computations that control behavior in health and disease.
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Recent advances in genetically encoded fluorescent probes have begun to address this need for rapid and localized readout of neuromodulator signaling. One approach takes a "nature knows best" strategy, in which endogenous receptor proteins are covalently conjugated to a circularly permuted fluorescent protein (cpGFP) to form chimeric receptors capable of translating ligand-binding-induced conformational changes to fluorescence signal intensity changes (Figure 2A,B) . These chimeric receptors can be expressed in the plasma membrane of select neuronal populations via genetic engineering strategies. This approach (albeit using a bacterial glutamate-binding protein) was previously used to create a glutamate-sensing fluorescent probe (iGluSnFr) 2 and has been expanded to the neuromodulator dopamine in two recent reports. 3, 4 Following parallel strategies, Patriarchi et al. and Sun et al. used the human dopamine receptor (DRD) to construct fluorescent dopamine probes named dLight1 and GRAB DA , respectively. Both were developed by optimized insertion of a cpGFP module into the third intracellular loop of human DRD subtypes: GRAB DA variants were constructed entirely from DRD2, and the most thoroughly characterized of the dLight1 variants were constructed from DRD1. The probes demonstrate similar performance: dLight1 variants exhibit maximal turn-on fluorescence responses (ΔF/F) from 200 to 300%, whereas GRAB DA reports a peak response of ∼100%. varying from 300 nM to 1.6 μM, and GRAB DA variants report a relatively narrow range of affinities (reported as EC 50 ) of 10−130 nM. In contrast to FSCV, both show selectivity for dopamine over its molecular analogue norepinephrine, with dLight1 demonstrating ≤70-fold selectivity and GRAB DA showing ≤10-fold selectivity. Both probes exhibit stable fluorescence and efficiently traffic to the plasma membrane, affording high signal-to-noise ratios that enable video-rate fluorescence imaging. Importantly, both dLight1 and GRAB DA did not exhibit ligand-induced changes in cAMP, providing preliminary evidence that the probes do not interfere with endogenous GPCR signaling.
The authors demonstrated the utility of dLight1 and GRAB DA across an impressive list of in vitro cell cultures, ex vivo brain slices, and awake, behaving animals ( Figure 3) . From a practical standpoint, the spectral profile of dLight1 and GRAB DA probes fits seamlessly into existing imaging setups utilized by many neuroscience laboratories. Furthermore, the optical versatility of the probes easily enables multiplexing: for instance, in vivo dopamine sensor imaging can be combined with calcium imaging or optogenetic stimulation using redshifted calcium indicators (jRGECO) or optogenetic actuators (ChrimsonR), respectively (see Figure 3A−C) .
These new probes demonstrate how advances in fluorescence microscopy, genetics, and protein engineering intersect to accelerate neuroscience research. Protein-based probes rely on genetic model organisms, which motivates parallel development of synthetic approaches that do not require gene delivery and may offer more seamless deployment and orthogonal readouts to their protein-based counterparts. A recent carbon nanoparticlebased catecholamine probe, named nIRCat, provides a purely synthetic alternative to genetically encoded dopamine probes ( Figure 2C,D) . 5 nIRCats have demonstrated optical dopamine detection in ex vivo brain slices at similar spatial and temporal resolutions achieved by dLight1 and GRAB DA . Though nIRCat lacks selectivity for dopamine over norepinephrine compared to dLight1 and GRAB DA , nIRCats demonstrate unaltered performance in the presence of dopamine receptor-binding drugs, thus enabling full-panel pharmacological studies of dopamine modulation. nIRCats also exhibit other advantages, including the relatively tissue-penetrating wavelength of its near-infrared emission spectra, and hours-long photostability.
To gain a holistic understanding of brain neurochemical function, scalable tools that can measure neurochemistry at spatial and temporal domains commensurate with brain function are needed. Both dLight1 and GRAB DA , and new synthetic probes like nIRCat, offer complementary capabilities and have expanded the optical tool kit available to the neuroscientist in exciting ways, ushering in a new era for the study of brain neurochemistry.
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